On February 22, 2018, Aptar Pharma will host a live educational webinar on the benefits of connected drug delivery devices, with a particular focus on improving patient regimen compliance.
This free interactive webinar is primarily aimed at R&D Managers and Engineers, Brand Marketing Managers, and Device and Packaging Engineers, as well as Product Managers within Pharma companies.
Entitled 'Digital Healthcare: Are you ready to connect?', the webinar will be hosted by Sai Shankar, Aptar Pharma's Director, Global Business Development - Connected Devices at Aptar Pharma. He will offer insight into the benefits that connected health devices can bring to the whole healthcare ecosystem, such as better patient adherence and health outcomes.
Key topics that will be covered include:
How to select an intuitive drug delivery system to enable greater patient compliance
How to successfully improve patient health outcomes through connected health technology
How connected devices benefit each part of the supply chain
How connected devices meet regulatory requirements
'Digital Healthcare: Are you ready to connect?'
takes place at 15.00 GMT on February 22, 2018.
To find out more about connected health solutions, please visit www.aptar.com/pharma.
AptarGroup Inc. published this content on 25 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 January 2018 19:49:01 UTC.
Original documenthttp://news.aptar.com/solutions/join-aptar-pharmas-educational-webinar-digital-healthcare-are-you-ready-to-connect/
Public permalinkhttp://www.publicnow.com/view/E3A2243A5BAAD789B2DD9345EB1CABA91448533E
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
